We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+7.16%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
AUM
$2.72B
AUM Growth
+$1.26B
Cap. Flow
-$390M
Cap. Flow %
-14.37%
Top 10 Hldgs %
63.11%
Holding
138
New
54
Increased
15
Reduced
11
Closed
39

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$109M
2
AMGN icon
Amgen
AMGN
+$53.5M
3
CELG
Celgene Corp
CELG
+$30.6M
4
FDC
First Data Corporation
FDC
+$27.3M
5
TFC icon
Truist Financial
TFC
+$23.2M

Sector Composition

Rank Sector Weight
1 Miscellaneous 78.7%
2 Healthcare 7.97%
3 Technology 6.1%
4 Communication Services 2.23%
5 Financials 1.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$339M 12.49%
+1,200,000
New +$326M
QCOM icon
2
PUT
Qualcomm
QCOM
$175B
$179M 6.61%
3,146,500
+1,099,400
+54% +$59.3M
ICPT
3
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$162M 5.97%
1,449,900
+615,300
+74% +$67.2M
AMGN icon
4
PUT
Amgen
AMGN
$234B
$160M 5.9%
+843,100
New +$161M
BIIB icon
5
PUT
Biogen
BIIB
$32.3B
$82M 3.02%
+346,800
New +$109M
BIIB icon
6
Biogen
BIIB
$32.3B
$82M 3.02%
+346,700
New +$109M
MDCO
7
PUT
DELISTED
Medicines Co
MDCO
$65.3M 2.4%
2,334,800
+887,800
+61% +$20.9M
QCOM icon
8
CALL
Qualcomm
QCOM
$175B
$61.2M 2.25%
+1,072,800
New +$57.9M
AMGN icon
9
Amgen
AMGN
$234B
$53.2M 1.96%
+280,220
New +$53.5M
LLL
10
DELISTED
L3 Technologies, Inc.
LLL
$46.7M 1.72%
226,058
+50,000
+28% +$9.9M
ABBV icon
11
PUT
AbbVie
ABBV
$451B
$40.3M 1.48%
+500,000
New +$40.9M
CELG
12
DELISTED
Celgene Corp
CELG
$33M 1.22%
+350,000
New +$30.6M
RHT
13
DELISTED
Red Hat Inc
RHT
$31.1M 1.14%
170,000
+15,000
+10% +$2.69M
FDC
14
DELISTED
First Data Corporation
FDC
$30.2M 1.11%
+1,150,000
New +$27.3M
ULTI
15
DELISTED
Ultimate Software Group Inc
ULTI
$23.1M 0.85%
+70,000
New +$21.5M
TFC icon
16
Truist Financial
TFC
$61.6B
$22.1M 0.81%
+474,695
New +$23.2M
QCOM icon
17
Qualcomm
QCOM
$175B
$19.5M 0.72%
341,251
-1,157,431
-77% -$62.5M
AABA
18
DELISTED
Altaba Inc
AABA
$18.5M 0.68%
250,000
+68,618
+38% +$4.72M
ITCI
19
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$18.3M 0.67%
1,503,100
-725,400
-33% -$9.27M
USG
20
DELISTED
Usg
USG
$18.2M 0.67%
420,000
+22,598
+6% +$975K
ONCE
21
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$14.8M 0.55%
+130,000
New +$9.55M
BMY icon
22
CALL
Bristol-Myers Squibb
BMY
$136B
$14.3M 0.53%
+300,000
New +$14.9M
GG
23
DELISTED
Goldcorp Inc
GG
$13.7M 0.51%
+1,200,000
New +$12.9M
IDTI
24
DELISTED
Integrated Device Technology I
IDTI
$13.2M 0.49%
270,000
-90,000
-25% -$4.36M
WP
25
DELISTED
Worldpay, Inc.
WP
$11.8M 0.44%
+104,400
New +$9.47M

Similar funds

DLD Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, DLD Asset Management held 138 positions worth $2.72B, up 86% from $1.46B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

DLD Asset Management withdrew a net $390M in Q1 2019, closing 39 positions and reducing 11 holdings. Its most notable exit was Shire pic, an estimated $38M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, up from 67% a quarter earlier, followed by Healthcare and Technology.

Against the trend, DLD Asset Management opened a new position in Biogen worth $82M.

  • DLD Asset Management's largest Q1 2019 buy was Biogen: 346,700 shares worth $82M.
  • DLD Asset Management added most to L3 Technologies, Inc. in Q1 2019, an estimated $9.9M increase.
  • DLD Asset Management's biggest Q1 2019 reduction was Qualcomm, cutting an estimated $62.5M.
  • DLD Asset Management fully exited Shire pic in Q1 2019, selling an estimated $38M.
  • DLD Asset Management's ten largest holdings make up 63% of its $2.72B portfolio in Q1 2019.
  • DLD Asset Management opened 54 new positions and closed 39 in Q1 2019.
  • DLD Asset Management's portfolio value rose 86% quarter-over-quarter to $2.72B.

Based on DLD Asset Management's 13F filing for Q1 2019, filed 14 May 2019.